Press release
Pharmacogenomic (PGx) Testing Market to Record Ascending Growth during 2021-2031; Increasing Use of Patient Specific Treatment to Boost Market Demand
Pharmacogenomic (PGx) testing is study of the effect of individual genetic make-up on the therapeutic effect of the medication. The individual response to the medication is determined by the various factor such as weight, age, diet, habits, and genetic factors, etc. The genetic make-up of the individual majorly decides the metabolism rate of the medication along with other factors. Depending on the variation in person to person gene make-up, metabolism of the medication varies significantly. One drug that works efficiently may not work for the other person due to variation in the time for metabolism.The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind increasing demand of Pharmacogenomic (PGx) Testing. Pharmacogenomic (PGx) Testing market drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review are addressed in the Pharmacogenomic (PGx) Testing market survey report. The survey report provides a comprehensive analysis of Pharmacogenomic (PGx) Testing market key trends and insights on Pharmacogenomic (PGx) Testing market size and share.
To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=3143
Pharmacogenomic (PGx) Testing Market: Segmentation
The global pharmacogenomic (PGx) testing market is segmented based on the by test type, application, end user and region
By test type pharmacogenomic (PGx) testing market is segmented as:
• Therapeutic Tests
• Diagnostic Tests
By application, the global pharmacogenomic (PGx) testing market is segmented as:
• Oncology
• Cardiovascular
• Others
By end user, global pharmacogenomic (PGx) testing market is segmented as:
• Diagnostic Laboratories
• Research Laboratories
• Academic Research Institutes
Key questions answered in Pharmacogenomic (PGx) Testing Market Survey Report:
• What is the current scenario and key trends in Pharmacogenomic (PGx) Testing Market?
• What are the key strategies companies are adopting to increase their consumer base?
• What are the key categories within the Pharmacogenomic (PGx) Testing segments and their future potential?
• What are the major Pharmacogenomic (PGx) Testing Market drivers and their expected impact during the short, medium, and long terms?
• What is the Pharmacogenomic (PGx) Testing Market size and what are the opportunities for the key players?
Pharmacogenomic (PGx) Testing Market: Key Players
The key market players operating in the pharmacogenomic (PGx) testing market are: Affymetrix, Inc., Becton Dickinson and Company, Bayer AG, Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., AstraZeneca PLC, QIAGEN and others.
The research report presents a comprehensive assessment of the Pharmacogenomic (PGx) Testing market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.
Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=3143
Essential Takeaways from the this Market Report
• Comparison of prominent players operating in the market.
• Recent developments and key strategies adopted by key players.
• Study of the micro and macro-economic growth indicators.
• Impact of the various factors on the value chain.
• Evaluation of current Pharmacogenomic (PGx) Testing market size, forecast and technological advancements within the industry.
• Current Insights influencing the scenario and key trends in Pharmacogenomic (PGx) Testing market.
Pharmacogenomic (PGx) Testing Market: Regional Outlook
The global pharmacogenomic (PGx) testing market is dominated by the North America due to availability of high end products for the pharmacogenomic (PGx) testing. Europe is expected to be second most lucrative pharmacogenomic (PGx) testing market in due to higher reports of adverse reactions and for the prevention more physicians are preferring use of pharmacogenomic (PGx) testing. Asia-Pacific is the emerging market due to increasing awareness about the availability of such pharmacogenomic (PGx) testing to minimize adverse events.
The Report Covers Exhaustive Analysis On:
• Pharmacogenomic (PGx) Testing Market Drivers, Segments and Restraints.
• Pharmacogenomic (PGx) Testing Market Survey and Dynamics
• Pharmacogenomic (PGx) Testing Market Size & Demand
• Pharmacogenomic (PGx) Testing Key Trends/Issues/Challenges
• Pharmacogenomic (PGx) Testing Sales, Competition & Companies involved
Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=3143
Explore Fact.MR’s Coverage on the Healthcare Domain:
Preparative Chromatography Market – https://www.factmr.com/report/preparative-chromatography-market
Leukocyte Count Testing Market – https://www.factmr.com/report/leukocyte-count-testing-market
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomic (PGx) Testing Market to Record Ascending Growth during 2021-2031; Increasing Use of Patient Specific Treatment to Boost Market Demand here
News-ID: 2531443 • Views: …
More Releases from Fact.MR
Corrosion under Insulation Monitoring Market is Projected to Reach USD 475.2 Mil …
The global corrosion under insulation (CUI) monitoring market is valued at USD 140 million in 2025 and is projected to grow at a CAGR of 13.0%, reaching USD 475.2 million by 2035. This expansion reflects the increasing need for advanced monitoring solutions in industries like oil & gas, chemical, and power, where CUI poses significant risks to infrastructure integrity. Historical growth from 2020 to 2024 was at a CAGR of…
Modular Biometric Access Control Terminals Market Valued at US$ 1.3 Billion in E …
Modular Biometric Access Control Terminals Market is projected to grow from USD 11.3 billion in 2025 to USD 31.4 billion by 2035, expanding at a CAGR of 10.8% during the forecast period. This significant growth is driven by advancements in technology, transitioning from manual lock systems to electronic entry systems, and the widespread adoption of modular biometric terminals for enhanced security. These systems are increasingly vital in commercial, residential, and…
U.S. Patient Positioning System Market Growth Supported by Rising Diagnostic and …
The U.S. patient positioning system market was valued at USD 228 million in 2024 and is projected to grow at a CAGR of 4.5% from 2025 to 2035, reaching USD 370 million by the end of the forecast period. This growth represents an absolute dollar opportunity of USD 131.6 million, driven by increasing surgical procedures, technological advancements, and rising healthcare needs. Historically, the market expanded at a CAGR of 4.0%…
Mixed Mode Chromatography Resin Market is Projected to Reach USD 743 Million and …
Mixed mode chromatography resins market is valued at USD 172 million in 2025 and is projected to grow at a CAGR of 15.7%, reaching USD 743 million by 2035. These resins use multimodal ligands, enabling protein binding through ionic, hydrogen bonding, and hydrophobic interactions, offering improved selectivity, resolution, and capacity compared to single-mode systems. This growth is driven by the increasing demand for sophisticated purification methods in biologics and biosimilar…
More Releases for PGx
Pharmacogenomics (PGX) Market Key Innovations 2025-2032
The Pharmacogenomics (PGX) market is at the forefront of a transformative wave in personalized medicine, revolutionizing how healthcare professionals approach treatment plans based on individual genetic profiles. PGX merges pharmacology and genomics to tailor drug therapies, enhancing efficacy and minimizing adverse effects. As the healthcare landscape evolves, the demand for PGX solutions is surging, driven by a growing emphasis on precision medicine, which seeks to optimize therapeutic outcomes for patients.
Recent…
Pharmacogenomics (PGx) Market Size, Trends 2031 By Key Players- Abbott Laborator …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Pharmacogenomics (PGx) Market size was valued at USD 16.5 Billion in 2023 and is projected to reach USD 32.1 Billion By 2031, growing at a CAGR of 9.17% during the forecast period 2024 to 2031.
The Pharmacogenomics (PGx) Market presents significant opportunities for growth driven by the increasing demand for personalized medicine and advancements in genomic technologies. Pharmacogenomics, which studies…
Pharmacogenomics (PGx) Market Skyrocketing Revenue Growth of USD 11.63 Billion, …
The global Pharmacogenomics (PGx) Market is expected to grow from USD 6.73 billion in 2020 to USD 11.63 billion by 2030, at a CAGR of +7% during the forecast period 2022-2030.
Pharmacogenomics (PGx), is the study of how people respond differently to drug therapy based upon their genetic makeup. Pharmacogenomics is part of the field of precision medicine, which aims to treat each patient individually. It uses genomic information to study…
Pharmacogenomics (PGx) Market with High Grow in CAGR of +8% with Prominent Key P …
According to The Global Market Vision, the Latest research report on "Pharmacogenomics (PGx) Market size accounted for $5,312.8 million in 2022 and is projected to reach $10,265.5 million by 2030, registering a CAGR of +8% from 2022 to 2030.
The increase in the elderly population, the surge in the adoption of pharmacogenomics procedures by healthcare professionals, growing awareness of the patient population towards personalized therapy, and growth in prevalence of chronic…
Demand For Pharmacogenomic (Pgx) Testing Is Slated To Rise At An 8% CAGR Through …
This research report on the worldwide Pharmacogenomic (PGx) Testing market analyses the market conditions and attain prominent aspects such as industry dynamics, key players, product segments, and leading applications. Besides this report presents insights into the global trends in the Pharmacogenomic (PGx) Testing market and recent developments in the market globally. The research is done keeping eye on the revenue potential and Pharmacogenomic (PGx) Testing market share. Apart from the…
Global Pharmacogenomics (PGx) Market 2022 Key Indicators - Abbott Laboratories, …
The market study based on the Global Pharmacogenomics (PGx) Market published by The Brainy Insights provides an up-to-date and accurate market picture. It also provides important data on the various components which affect the progress of the Pharmacogenomics (PGx) market through a brief scan and detailed information. The report will help stakeholders and partners define the best development methods and take advantage of the opportunities prevailing in the Pharmacogenomics (PGx) market. A…
